Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/06/2024 | PARALLEL ADVISORS, LLC | 350 | $13 | 0.00% | 0.00% |
05/03/2024 | BAADER BANK AKTIENGESELLSCHAFT | 0 | $0 | -100.00% | 0.00% |
05/06/2024 | ADVISORY SERVICES NETWORK, LLC | 0 | $0 | -100.00% | 0.00% |
05/16/2024 | BEACON CAPITAL MANAGEMENT, LLC | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 14 institutional investors and hedge funds held shares of Navidea Biopharmaceuticals, Inc.. The most heavily invested institutionals were:
Parallel Advisors, LLC: 350
Baader Bank Aktiengesellschaft: 0
Advisory Services Network, LLC: 0
Beacon Capital Management, LLC: 0
JPMORGAN CHASE & CO: 0
STATE STREET CORP: 0
A. 0.00% of Navidea Biopharmaceuticals, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 13,839 shares in the last 24 months. This purchase volume represents approximately $7 in transactions.